Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, phase IIIb study

B Trottier, JE Lake, K Logue, C Brinson… - Antiviral …, 2017 - journals.sagepub.com
Background Simplified dosing regimens are important for patients who face challenges in
adhering to HIV-1 therapy. We investigated the safety and virological efficacy of switching to …

[BOOK][B] Popular Disturbances in Scotland 1780-1815

KJ Logue - 2003 - books.google.com
… The right of Kenneth J. Logue to be identified as the author of this book has been asserted
by him in accordance with the Copyright, Designs and Patents Act 1988. … Kenneth J. …

Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada

…, MR Loutfy, R Kaul, KJ Logue… - AIDS patient care and …, 2008 - liebertpub.com
We sought to identify and review the clinical features and treatment outcomes of eight recent
cases of otosyphilis in HIV-positive patients seen in Toronto. All patients reported tinnitus, …

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine

…, RS Remis, MF Merid, M Rusch, J Vincelette, K Logue… - Cmaj, 2005 - Can Med Assoc
Background: Phase I and phase II HIV-1 vaccine trials have revealed increases in risky sexual
activity among study subjects during the trials, perhaps because the subjects believe that …

[HTML][HTML] Cross-sectional comparison of age-and gender-related comorbidities in people living with HIV in Canada

…, C Fraser, G Rubin, R Thomas, H Loemba, K Logue… - Medicine, 2022 - journals.lww.com
Because antiretroviral therapy (ART) is allowing people living with human immunodeficiency
virus (PLWH) to survive longer, they are developing more age-related comorbidities. We …

[HTML][HTML] Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational …

A Wong, J Brunetta, J De Wet, K Logue, H Loemba… - Medicine, 2024 - journals.lww.com
The BICSTaR (BICtegravir Single Tablet Regimen) study is investigating the effectiveness
and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in people with human …

Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label …

B Trottier, JE Lake, K Logue, C Brinson… - Antiviral …, 2017 - journals.sagepub.com
… Trottier B, Lake JE, Logue K, et al. Dolutegravir/abacavir/ lamivudine versus current ART
in virally suppressed patients (STRIIVING): a 48-week, randomized, noninferiority, open-label …

[HTML][HTML] Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments

B Conway, J DeWet, A Tsang, K Logue… - Journal of the …, 2008 - Springer
Methods This is an ongoing 96-week, observational, open-label, multicenter study. Patients
were prescribed the standard dose of lopinavir/ritonavir (400 mg/100 mg) twice a day. Other …

Mitchell, The Irish in the West of Scotland

KJ Logue - Scottish Historical Review, 2001 - euppublishing.com
It is perhaps the fate of many Ph. D. students to toil in an area of work which is interesting,
indeed critical to an understanding of an historical moment or period, but to find, when they get …

SECTARIANISM AND ANTISECTARIANISM

OS Walls, K Logue - Peacebuilding: A Field Guide, 2001 - books.google.com
The definition of what we mean by antisectarianism depends on what we mean by sectarianism.
It is not fully possible to entrap the nuances of feelings, passions, intellectual niceties, or …